Local Regulatory Experts
Connect with regulatory affairs consultancies specializing in this region.
Qualtech Consulting Corporation
Taiwan, China, Japan, Singapore, Hong Kong, Malaysia, Philippines, Vietnam, Australia, Germany, Korea, Thailand, USA
A specialized medical device consulting firm offering a one-stop solution for complex global regulatory challenges. We offer real-time regulatory and clinical support, local representation, and QMS services across 13 markets, ensuring efficient market entry and compliance.
Cobridge Co., Ltd.
Tokyo, Japan
We assist medical device companies with the medical device registration and approval in Japan. Regulatory consulting services and DMAH services for foreign manufacturers to enter Japanese market.
MDREX, Medical Device, Digital Health Consulting Group
Seoul, Republic of Korea (HQ), Japan Office
We offer total solutions for market entry in South Korea and global expansion (e.g., Japan, USA, Europe). Key areas include product approval, reimbursement listings (HIRA), and Quality System certification (KGMP). They are particularly strong in innovative products like SaMD, medical wearables, and 3D printing for medical use, and provide in-depth expertise in cybersecurity and clinical trial planning.
CMIC Holdings Co., Ltd.
Tokyo, Japan (HQ), Osaka, Japan, Beijing, China, Seoul, South Korea, Taipei, Taiwan, Singapore, New York, USA, London, UK, Frankfurt, Germany, Sydney, Australia
We operate globally, specializing in accelerating the development, manufacturing, and commercialization of drugs and medical devices. Their expertise spans Phase I to IV clinical trials, regulatory affairs, quality assurance, and manufacturing, with a strong focus on the Japanese and Asian markets. Key services include clinical operations (CRO), manufacturing (CDMO/CMO), site management (SMO), and comprehensive health analysis and solutions.
December 25, 2025
Approximately 5 minutes
Points to Consider for the Preparation of Applications for Marketing Approval of Remanufactured Single-use Medical Devices in Japan
Points to Consider for the Preparation of Applications for Marketing Approval of Remanufactured Single-use Medical Devices in Japan
Overview
Japan’s Ministry of Health, Labour and Welfare (MHLW) issued the “Points to Consider for the Preparation of Applications for Marketing Approval of Remanufactured Single-use Medical Devices” to provide detailed instructions for applicants on how to prepare marketing approval applications for remanufactured single-use medical devices (R-SUDs). This guidance forms part of the regulatory framework under the Pharmaceuticals and Medical Devices Act (PMD Act) and related Enforcement Regulations. :contentReference[oaicite:0]{index=0}
Key Application Content Requirements
Scope & Definitions
- The guidance applies to products recognized as remanufactured single-use medical devices (R-SUDs) under the Enforcement Regulations.
- Definitions include the remanufacturing process, component recycling process, and final production process which span from receipt of used devices to release of the remanufactured product. :contentReference[oaicite:1]{index=1}
Application Structure
Applicants must complete all required fields of the marketing approval form, including:
- Category – Should match the category of the original single-use medical device (SUD).
- Name – Generic name must begin with “reprocessed”. Brand name must include “reprocessed” and the marketing authorization holder’s name.
- Intended Use/Indications – Must not exceed those of the original device.
- Shape, Structure, and Principle – Detailed information on recyclable and replacement components is required.
- Raw Materials – Describe materials of recyclable and replacement components, including maximum number of reprocessing cycles.
- Performance and Safety Specifications – Detailed performance and safety data comparable to the original device. :contentReference[oaicite:2]{index=2}
Manufacturing & Traceability
- Include detailed reprocessing flow charts and description of each step: receipt, disassembly, cleaning, sterilization, and storage.
- Explain traceability methods that link recycled parts to finished products throughout the process. :contentReference[oaicite:3]{index=3}
Use & Shelf Life
- Intended use methods must mirror those of the original device.
- Shelf life must be supported by stability data and specify differences by number of reprocessing cycles if applicable. :contentReference[oaicite:4]{index=4}
Q&A
Q: What must be shown about the intended use of an R-SUD?
A: The intended use or indications of the remanufactured device must not exceed those of the original single-use device. :contentReference[oaicite:5]{index=5}
Q: Must traceability be included in the application?
A: Yes. Applicants must describe methods to ensure traceability from collection of used parts to distribution of remanufactured products. :contentReference[oaicite:6]{index=6}
Q: Are replacement components treated differently?
A: Yes. Replacement components must be described with specifications and their own reprocessing cycle information. :contentReference[oaicite:7]{index=7}
Conclusion
This guidance ensures that applications for R-SUDs are complete, scientifically justified, and demonstrate that remanufactured products meet standards equivalent to original devices. :contentReference[oaicite:8]{index=8}
Related Articles
Approximately 5 minutes
Japan Medical Device Registration: Pathways and Requirements
The medical device registration process in Japan is overseen by the PMDA and varies significantly based on device classification (Class I to IV). Key pathways include Pre-Market Submission (PMS), Pre-Market Certification (PMC), and Pre-Market Approval (PMA).
Approximately 5 minutes
Japan Medical Device Local Labeling Requirements: Tempu Bunsho
Medical device labeling in Japan, specified by PMDA's Article 52, mandates the use of Japanese 'tempu bunsho' (package inserts/IFUs). This process involves rigorous content requirements, notification upon revision, and MAH/DMAH oversight for affixation.
Approximately 5 minutes
Japan Medical Device Post-Market Surveillance (PMS): GVP and Adverse Event Reporting
An overview of Japan's PMS requirements under the PMD Act, focusing on the MAH's GVP compliance, the mandatory reporting of adverse events (Fuguai), and the strict reporting timelines (e.g., 15 days for death or serious, unanticipated events).
Approximately 5 minutes
Japan Specialty Fulfillment for Medical Devices: Low Volume, High Value Sales
Specialty Fulfillment is a crucial service for foreign medical device manufacturers targeting low-volume, high-value sales in Japan, often utilizing an Independent License Holder to manage customs, storage, and distribution to maintain high profit margins.
Approximately 5 minutes
Regulatory Science in Japan: PMDA’s Evidence-Based Approach to Innovation and Public Health
This article explains what “regulatory science” means in Japan and how the PMDA advances it through organizational structures, expert deliberation, collaborations, and research dissemination. A practical Q&A is included for industry and academia.